Your browser doesn't support javascript.
loading
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.
Gupta, Vikas; Kim, Soyoung; Hu, Zhen-Huan; Liu, Ying; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Gadalla, Shahinaz M; Gale, Robert Peter; Ganguly, Siddhartha; George, Biju; Gerds, Aaron T; Gergis, Usama; Hamilton, Betty K; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Kamble, Rammurti T; Kindwall-Keller, Tamila; Lazarus, Hillard M; Liesveld, Jane L; Litzow, Mark; Maziarz, Richard T; Nishihori, Taiga; Olsson, Richard F; Rizzieri, David; Savani, Bipin N; Seo, Sachiko; Solh, Melhem; Szer, Jeff; Verdonck, Leo F; Wirk, Baldeep; Woolfrey, Ann; Yared, Jean A; Alyea, Edwin P; Popat, Uday R; Sobecks, Ronald M; Scott, Bart L; Nakamura, Ryotaro; Saber, Wael.
Afiliação
  • Gupta V; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kim S; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, and.
  • Hu ZH; Institute of Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI.
  • Liu Y; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, and.
  • Aljurf M; Mental Health Data Science, Department of Psychiatry, Columbia University Irving Medical Center, New York, NY.
  • Bacher U; Department of Oncology, King Faisal Specialist Hospital Center and Research Center, Riyadh, Saudi Arabia.
  • Beitinjaneh A; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Cahn JY; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL.
  • Cerny J; Department of Hematology, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Grenoble, France.
  • Copelan E; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA.
  • Gadalla SM; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Gale RP; Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD.
  • Ganguly S; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • George B; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS.
  • Gerds AT; Christian Medical College, Vellore, India.
  • Gergis U; Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Hamilton BK; Division of Hematological Malignancies, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.
  • Hashmi S; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Hildebrandt GC; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Kamble RT; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Kindwall-Keller T; Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Lazarus HM; Division of Hematology and Oncology, Center for Cell and Gene Therapy, College of Medicine, Baylor University, Houston, TX.
  • Liesveld JL; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA.
  • Litzow M; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH.
  • Maziarz RT; Department of Medicine, University of Rochester Medical Center, Rochester, NY.
  • Nishihori T; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN.
  • Olsson RF; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Rizzieri D; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL.
  • Savani BN; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Seo S; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Solh M; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC.
  • Szer J; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Verdonck LF; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Wirk B; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA.
  • Woolfrey A; Clinical Haematology, Peter MacCallum Cancer Centre/The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Yared JA; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
  • Alyea EP; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA.
  • Popat UR; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Sobecks RM; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD.
  • Scott BL; Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Nakamura R; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Saber W; Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH; and.
Blood Adv ; 4(19): 4748-4757, 2020 10 13.
Article em En | MEDLINE | ID: mdl-33007075
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos